Search

Search Constraints

You searched for: Author/Creator Gartrell, Jessica

Search Results

1. A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies. (September 2020)

2. Allosteric regulation of DNA binding and target residence time drive the cytotoxicity of phthalazinone-based PARP-1 inhibitors. Issue 12 (15th December 2022)